Research Center Profile:
Protenium Clinical Research
Cardiology/Vascular Diseases
Endocrinology
Family Medicine
Gastroenterology
Hematology
Immunology
Infections and Infectious Diseases
Musculoskeletal
Nephrology
Neurology
Nutrition and Weight Loss
Obstetrics/Gynecology (Women’s Health)
Ophthalmology
Otolaryngology (Ear, Nose, Throat)
Psychiatry/Psychology
Pulmonary/Respiratory Diseases
Rheumatology
Sleep
Urology
Protenium Clinical Research, formerly Texas FamiliCare Clinical Research, is an independent, privately owned clinical research facility specializing in Phase I, II, III and IV clinical trials in a wide range of therapeutic areas. Although Protenium was established in January 2000, its founder, Dr. Strzinek, has been involved in research for over thirty years.
PROTENIUM HAS EXPERIENCE IN THE FOLLOWING THERAPEUDIC AREAS:
- Alzheimer's Disease
- Artheosclerotic Heart Disease
- Anxiety Disorders
- Atopic Dermatitis
- Bronchitis
- Chronic Obstructive Lung Disease
- Constipation
- Contact Dermatitis
- Contraception
- Diabetes Mellitus
- Dyspepsia
- Female Sexual Dysfunction
- Gastroenteritis
- GERD
- Hypertension
- Hormone Replacement Therapy
- Irritable Bowl Syndrome
- Rheumatoid Arthritis
- Rhinitis
- Sexual Disorders
- Sinusitis
- Sleep Disorders
|
- Lipid Disorders
- Menopause
- Migraine Headaches
- Mood Disorders
- Obesity
- Opioid-Induced Constipation
- Osteoarthritis
- Otitis Media
- Overactive Bladder
- Pain Syndromes
- Peripheral Vascular Disease
- Pharyngitis
- Pneumonia
- Postmenopausal Syndrome
- Prostatic Disorders
- Psoriasis
- Respiratory Tract Infection
- Stroke Prevention
- Stroke Rehabilitation
- Tonsillitis
- Vaginitis
|
PROTENIUM IS PROUD TO HAVE PARTNERED WITH THE FOLLOWING COMPANIES:
- AGI Therapeutics
- Altana Pharma
- AstraZeneca International
- Bayer
- BioSante Pharmaceutical, Inc.
- Bristol-Myers Squibb
- Covance
- Daiichi Sankyo Company LTD
- Diasome Pharmaceuticals
- Forest Research Institute
- GlaxoSmithKline
- Grunenthal
- ISS
- Johnson & Johnson
- Merck & Company
- Mannkind Corp
- Meda Pharmaceuticals
- MedPace, Inc.
|
- Novartis Pharmaceuticals Corporation
- Novo Nordisk, Inc.
- DepoMed, Inc.
- Parexel International
- Pfizer, Inc.
- PPD, Inc.
- PRA International
- Proctor & Gamble
- Purdue Pharma, LP
- Quintiles
- Replidyne, Inc.
- Sanofi Aventis
- Solvay
- Schwarz Pharma
- Sucampo Pharmaceuticals
- Takeda Global Research Center
- Tolerx
- Wyeth
|
Protenium Clinical Research is centrally located in Hurst, Texas (a suburb of the Dallas/Fort Worth Metroplex), approximately 10 miles from Dallas/Fort Worth International Airport and 20 miles from Dallas Love Field Airport.
Protenium Clinical Research offers the following site features and capabilities:
- CPR, ACLS certified personnel
- Phlebotomy
- Refrigerated centrifuge for lab specimen preparation
- Emergency medication & crash cart
- Automated external defibrillator
- 24-Hour treatment and observation of patients
- Dedicated drug storage area locked with keypad access
- Dedicated rooms for subject evaluation
- EKG equipment
- -20 & -70 degree Fahrenheit freezers
- 911 immediate response
- Fully equipped for gynecological evaluations
- Full service hospital within 3 miles
- Full radiology service within 2 blocks
- Outpatient surgical center for EGDs, colonoscopies, etc.
- Monitor Workstation equipped with high-speed internet and access to both copier and fax machines
- Conference Room
Although Dr. Robert Strzinek originally founded Protenium Clinical Research as Texas FamiliCare Clinical Research in 2000, he has been involved in research for over 30 years.
After graduating from South Oak Cliff High School, he received his Bachelor of Science Degree in Biology in 1964 from Abilene Christian University. He then attended University of North Texas where he earned a Masters Degree and a Ph.D. in Microbiology.
After graduating from UNT in 1970, Dr. Strzinek participated in post-doctoral research as a National Research Council Post-Doctoral Fellowship recipient at NASA Manned Space Craft Center in Houston, Texas.
Following his tenure at NASA, Dr. Strzinek served as Director of Research and Development at Helena Laboratories while teaching biochemistry at the University of Texas Medical Branch in Galveston, Texas. It was during this time that Dr. Strzinek made the commitment to become a physician and began his medical training at the University of North Texas - Health Science Center of Fort Worth. Dr. Strzinek completed his internship at the DFW Medical Center in 1979.
Today, Dr. Strzinek is a board certified family practice physician and has practiced medicine in the mid-cities area since 1979. The doctor is a Christian and cares deeply about the welfare of his patients. His hobbies include golf and spending time with family and friends.
Wade Strzinek – President
Mindy Matlock, BS, CCRC – Site Manager & Certified Clinical Research Coordinator
Christi Kelly, MS, CCRP – Certified Clinical Research Professional
Christina Pickering, MA – Clinical Research Coordinator
Tasha Bryant, MA – Clinical Research Associate
Lynette Hart – Study Recruitment
Protenium Clinical Research is located in Hurst, TX in the heart of the Dallas/Fort Worth Metroplex (population: 5.7 million, 2004 census). Protenium Clinical Research draws from a demographically diverse area ranging from 10-65% non-white in race. Similar diversity in age, education, language, and income can also be targeted for special studies.
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the email form below. A representative from
the research center will then follow up with you.
